title: Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate.
authors.forename: H A A M
authors.initials: HA
authors.lastname: van Vliet
authors.forename: T A
authors.initials: TA
authors.lastname: Winkel
authors.forename: I
authors.initials: I
authors.lastname: Noort
authors.forename: J
authors.initials: J
authors.lastname: Rosing
authors.forename: F R
authors.initials: FR
authors.lastname: Rosendaal
mesh_terms: D020016:Activated Protein C Resistance / Q000175:diagnosis; D000293:Adolescent; D000328:Adult; D000736:Androstenes / Q000009:adverse effects; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D017373:Cyproterone Acetate / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D019851:Thrombophilia / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000736:Androstenes; D003277:Contraceptives, Oral, Combined; D017373:Cyproterone Acetate; C035144:drospirenone